Hosted on MSN1d
Top 5 Biotech Stocks That Captured Retail Investor Interest The Most In 2024
U.S. biotech stocks, particularly small and mid-cap companies, remained a focal point for retail investors in 2024 despite ...
Exicure joins hands with GPCR Therapeutics for growth in biotech
Exicure (NASDAQ:XCUR) signed a MOU with GPCR Therapeutics aimed at the acquisition of GPCR USA, a subsidiary of GPCR ...
Food10d
All G achieves self-affirmed GRAS status for recombinant bovine lactoferrin
Sydney-based biotech company All G affirmed the GRAS status of its recombinant bovine lactoferrin, as the company tees up the ...
Food4d
Nuritas raises $42m Series C to boost market penetration
AI-based biotech peptide discovery company Nuritas is fueling its next stage of growth with $42m in fresh capital, led by M&G ...
Enid News & Eagle1mon
ENHERTU® Receives Prestigious 2024 Prix Galien USA Award for Best Biotechnology Product
TOKYO & BASKING RIDGE, N.J.--(BUSINESS WIRE)--Nov 8, 2024-- ...
USA News Group: How Cutting-Edge Immunotherapies Are Redefining Cancer Treatment Options
Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Dec. 23, 2024 /PRNewswire/ -- USA News Group News Commentary - Recent advancements in cancer treatment continue to underscore ...
USA News Group: Oncology Advancements Accelerate Amid Rising Early-Onset Cancer Diagnoses
USA News Group CommentaryIssued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Dec. 20, 2024 /PRNewswire/ -- USA News Group News Commentary - The American Cancer Society has published ...
Eagle-Tribune1mon
ENHERTU® Receives Prestigious 2024 Prix Galien USA Award for Best Biotechnology Product
Daiichi Sankyo (TSE:4568) and AstraZeneca (LSE/STO/Nasdaq: AZN) have been awarded The Galien Foundation 2024 Prix Galien USA Award for Best Biotechnology Product for ENHERTU ® (fam-trastuzumab ...